2637 — Fujian Haixi Pharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Fujian Haixi Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	312	275	273
Net Total Accounts Receivable
Net Total Receivables	8.04	25.1	26.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	350	334	346
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	45.7	144	322
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	421	562	756
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	90.1	117	182
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	133	156	214
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	288	405	541
Total Liabilities & Shareholders' Equity	421	562	756
Total Common Shares Outstanding